Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹1,681 Cr₹944 Cr₹973 Cr₹683 Cr₹710 Cr

What is the latest Total Current Liabilities ratio of NATCO PHARMA ?

The latest Total Current Liabilities ratio of NATCO PHARMA is ₹1,681 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹1,681 Cr
Mar2025₹944 Cr
Mar2024₹973 Cr
Mar2023₹683 Cr
Mar2022₹710 Cr

How is Total Current Liabilities of NATCO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2026 ₹1,681 Cr
78.16
Mar2025 ₹944 Cr
-3.01
Mar2024 ₹973 Cr
42.41
Mar2023 ₹683 Cr
-3.84
Mar2022 ₹710 Cr -

Compare Total Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,018.4 Cr -1.3% -8.6% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.3%

-8.6%

-4.2%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses